Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03647215
Recruitment Status : Recruiting
First Posted : August 27, 2018
Last Update Posted : October 29, 2019
Information provided by (Responsible Party):
Incyte Corporation ( Incyte Biosciences UK )

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 30, 2020
Estimated Study Completion Date : June 30, 2020